Review of a three-year meticillin-resistant Staphylococcus aureus screening programme

Journal of Hospital Infection

Volumn 78, Issue 2, 2011, Pages 81-85

  Collins, J ^a   Raza, M ^a   Ford, M ^a   Hall, L ^a   Brydon, S ^a   Gould, F K ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Meticillin resistant Staphylococcus aureus; Nose, throat and perineum; Targeted approach; Universal screening

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM DETECTION; COST EFFECTIVENESS ANALYSIS; CULTURE TECHNIQUE; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; PERINEUM; PREVALENCE; SCREENING TEST; THROAT CULTURE; TURNAROUND TIME; WORKLOAD;

BACTERIOLOGICAL TECHNIQUES; CARRIER STATE; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; ENGLAND; HOSPITALS, TEACHING; HUMANS; INFECTION CONTROL; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NOSE; PERINEUM; PHARYNX; PREVALENCE; PROGRAM EVALUATION; STAPHYLOCOCCAL INFECTIONS;

EID: 79955957250     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.02.012     Document Type: Article

References (35)

1. Harbarth S., Hawkey P.M., Tenover F., Stefani S., Pantosti A., Struelens M.J. Update on screening and clinical diagnosis of methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrobiol Agent 2011, 37:110-117.
2. Yang Y., McBride M.V., Rodvold K.A., et al. Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant by Staphylococcus aureus. Am J Health Syst Pharm 2010, 67:1017-1024.
3. Struelens M.J., Hawkey P.M., French G.L., Wittle W., Tacconelli E. Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening and typing: state of the art and unmet needs. Clin Microbiol Infect 2009, 15:112-119.
4. French G.L. Methods for screening for methicillin-resistant Staphylococcus aureus carriage. Clin Microbiol Infect 2009, 15(Suppl. 7):10-16.
5. Stürenburg E. Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations. Ger Med Sci 2009, 7. Doc06.
6. Harris A.D., Furuno J.P., Roghmann M.C., et al. Targeted MRSA surveillance and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother 2010, 54:3143-3148.
7. Vos M.C., Behrendt M.D., Melles D.C., et al. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol 2009, 30:977-984.
8. Haung S.S., Yokoe D.S., Hinrichsen V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus bacteraemia. Clin Infect Dis 2006, 43:971-978.
9. Simmons S. Effects of selective patient screening for MRSA on overall MRSA hospital-acquired infection rates. Crit Care Nurs Q 2011, 34:18-24.
10. Pearson A. Historical and changing epidemiology of healthcare-associated infections. J Hosp Infect 2009, 73:296-304.
11. Mears A., White A., Cookson B., et al. Healthcare-associated infections in acute hospital: which interventions are effective?. J Hosp Infect 2009, 71:307-313.
12. Donaldson L., Beasley C. Saving lives. A delivery programme to reduce healthcare associated infection including MRSA June 2005, Department of Health, London.
13. Office for National Statistics. Date last accessed,1 October 2010. http://www.statistics.gov.uk/cci/nugget.asp%3Fid%3D1067.
14. Donaldson L., Beasley C. Screening for MRSA colonisation: a summary of best practice. PL CMO(2006)4 2006, Department of Health, London.
15. Department of Health (England) The NHS in England: the operating framework for 2008/09 and 2009/10 2007, Department of Health, London.
16. Beasley C., Flory D. MRSA screening - operational guidance July 2008, NHS Finance, Performance and Operations, London.
17. Beasley C., Flory D. MRSA screening - operational guidance 2 December 2008, NHS Finance, Performance and Operations, London.
18. Beasley C., Flory D. MRSA screening - operational guidance 3 March 2010, NHS Finance, Performance and Operations, London.
19. Gurran C., Holliday M.G., Perry J.D., Ford M., Morgan S., Orr K.E. A novel selective medium for the detection of methicillin-resistant Staphylococcus aureus enabling result reporting in under 24 h. J Hosp Infect 2002, 52:148-151.
20. Wolk D.M., Picton E., Johnson D., et al. A multicentre evaluation of the Cepheid XpertTM MRSA test as a rapid screening method for detection of MRSA from nares swabs. J Clin Microbiol 2009, 47:758-764.
21. Jeyaratnam D., Whitty C., Phillips K., et al. Impact of rapid screening tests on acquisition of methicillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008, 336:927-930.
22. Bignardi G., Lowes S. MRSA screening: throat swabs are better than nose swabs. J Hosp Infect 2009, 71:373-388.
23. Harbarth S., Schrenzel J., Renzi G., Akakpo C., Ricou B. Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit?. J Clin Microbiol 2007, 45:1072-1073.
24. Bitterman Y., Laor A., Itzhaki S., Weber G. Characterisation of the best anatomical sites for MRSA colonisation. Eur J Clin Microbiol Infect Dis 2010, 29:391-397.
25. Mertz D., Frei R., Periat N., Zimmerli M., Battegay M. Exclusive Staphylococcus aureus throat carriage: at risk populations. Arch Int Med 2009, 169:172-178.
26. Batra R., Eziefula A.C., Wyncoll D., Edgeworth J. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Intensive Care Med 2008, 34:1703-1706.
27. Ringberg H., Petersson C.A., Walder H., Johansson H.P.J. The throat: an important site for MRSA colonisation. Scand J Infect Dis 2006, 38:888-893.
28. Weber S.G., Huang S.S., Oriola S. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: positive statement from the Joint SHEA and APIC Task Force. Am J Infect Control 2007, 35:73-85.
29. McGinigle K.L., Gourlay M.L., Buchana I.B. The use of active surveillance cultures in adult intensive care unit to reduce methicillin-resistant Staphylococcus aureus related morbidity, mortality and costs: a systemic review. Clin Infect Dis 2008, 46:1717-1725.
30. van Griethuysen A., Bes M., Etienne J., Zbinden R., Kluytmans J. International multicenter evaluation of latex agglutination tests for identification of Staphylococcus aureus. J Clin Microbiol 2001, 39:86-89.
31. Andrews J.M. BSAC Working Party on Susceptibility Testing. BSAC standardised disc susceptibility testing method (version 8). J Antimicrob Chemother 2009, 64:454-489.
32. Department of Health (England) Impact assessment of screening elective patients for MRSA. Version 0.3 November 2008.
33. Tacconelli E., de Angelis G., de Waure C., Cataldo M., la Torre G., Cauda R. Rapid screening tests for meticillin-resistant Staphylococcus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009, 9:546-554.
34. Tacconelli E. Screening and isolation for infection control. J Hosp Infect 2009, 73:371-377.
35. Reilly J.S., Stewart S., Christie P., et al. Universal screening for methicillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project. J Hosp Infect 2010, 74:35-41.